ArticleAnnals of translational medicine2017

ALK on my mind: alectinib takes an early lead in managing intracranial disease in non-small cell lung cancer with ALK rearrangements.

Phu N Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.